SecBot SecBot
8-K ·Filed Aug 18, 2026

BAX

BAXTER INTERNATIONAL INC
MIXED
Impact 5/10
Horizonweeks Processed3mo ago SEC0001628280-26-057739
8-K material event: Items 1.01
Actionable Insight ◆ Mixed

The covenant relaxation signals that Baxter's leverage is under pressure, likely from post-Hillrom debt and the Kidney Care divestiture. The debt buyback at a discount is a modest credit positive, reducing interest expense. Watch for the next 10-Q to see if leverage is actually below the 4.25x threshold; if it's tight, the stock may remain range-bound.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$26.64
T+0 close · Aug 18, 2026 · via day close
Latest settled
−3.38%
T+60 · $25.74
Vs SPY
−1.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 19 $26.64entry
  2. T+1 · 3mo ago −0.86%α −0.02% · $26.41
  3. T+5 · 3mo ago −0.53%α −0.14% · $26.50
  4. T+20 · 2mo ago −13.59%α −11.64% · $23.02
  5. T+60 · 5d ago −3.38%α −1.83% · $25.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Baxter entered into Amendment No. 2 to its credit agreement, relaxing the net leverage ratio covenant for the next five quarters (maintaining it at 4.25x through Sep 2027 instead of stepping down) and removed a subsidiary borrower. Separately, the company completed a $600M cash tender offer for four series of senior notes, upsized from $500M, retiring ~$864M in principal at a discount. The covenant relief signals near-term financial strain, while the debt buyback at a discount is a modest credit positive, reducing interest expense and extending runway.

Key Facts

  • Baxter amended its credit agreement to keep the maximum net leverage ratio at 4.25x through September 30, 2027, instead of stepping down to 4.00x in Sep 2027 and 3.75x thereafter.
  • Baxter completed a $600M cash tender offer (upsized from $500M) for four series of senior notes, accepting $864M in principal at a discount.
  • The tender offer accepted 100% of tendered 3.132% notes due 2051 ($422M), 3.500% notes due 2046 ($132M), and 4.500% notes due 2043 ($73M), plus 31.37% of tendered 2.539% notes due 2032 ($237M).
  • Baxter World Trade SRL was removed as a borrower under the credit agreement.
  • The company paid an early tender premium of $30 per $1,000 principal amount.
  • No Final Settlement Date will occur; all notes tendered after Aug. 17, 2026 will be returned.

Financial Impact

Baxter retired ~$864M in principal for $600M in cash, a ~$264M discount. The covenant relaxation provides breathing room on leverage through Sep 2027.

debtleverageinterest expense

Risk Factors

  • Leverage may remain elevated, constraining financial flexibility.
  • The company's dividend was recently cut to $0.01/share, indicating ongoing cash preservation.
  • Forward-looking statements highlight risks from supply chain, inflation, and competition.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
25% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-057739
Document: bax-20260818exhibit992.htm0001628280-26-057739
Document: bax-20260818exhibit991.htm0001628280-26-057739
Document: bax-20260818.htm0001628280-26-057739
Document: 0001628280-26-057739-index-headers.html0001628280-26-057739
Document: 0001628280-26-057739-index.html0001628280-26-057739
Document: 0001628280-26-057739.txt0001628280-26-057739

Track record

15 reports on BAX

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +9.15% at T+5 after the Oct 29, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $23.50 to $25.65 Now $25.54 +8.68% ▲ +9.15% +13.87% vs SPY
  2. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $24.92 to $25.49 Now $25.54 +2.49% ▲ +2.29% +4.28% vs SPY
  3. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $25.30 to $23.00 Now $25.54 +0.95% ▼ −9.09% −8.53% vs SPY
  4. Aug 19, 202612w ago 8-K Neutral 3/10 Entry $26.64 to $26.50 Now $25.54 −4.13% ▼ −0.53% −0.14% vs SPY
  5. Aug 18, 202612w ago 8-K Mixed 5/10 Viewing Entry $26.64 to $26.50 Now $25.54 −4.13% ▼ −0.53% −0.14% vs SPY
  6. Aug 12, 202613w ago Institutional Cluster Bullish 4/10 Entry $26.95 to $26.64 Now $25.54 −5.23% ▼ −1.15% −0.71% vs SPY
  7. Aug 4, 202614w ago 8-K Neutral 4/10 Entry $28.35 to $27.61 Now $25.54 −9.91% ▼ −2.61% −2.51% vs SPY
  8. Jul 30, 202615w ago 8-K Bullish 7/10 Entry $26.75 to $27.01 Now $25.54 −4.52% ▲ +0.97% −2.65% vs SPY
  9. Jun 11, 202622w ago Institutional Cluster Bearish 6/10 Entry $20.49 to $19.39 Now $25.54 −24.65% ▲ +5.37% +5.80% vs SPY
  10. May 8, 202627w ago 8-K Neutral 2/10 Entry $17.53 to $17.79 Now $25.54 +45.69% ▲ +1.48% +1.57% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (11h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 18, 2026